ABLYNX TO PRESENT AT THE JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE IN LONDON
(Thomson Reuters ONE) -
GHENT, Belgium, 17 November 2014 - Ablynx [Euronext Brussels: ABLX] today
announced that it will present at the Jefferies 2014 Global Healthcare
Conference at the Waldorf Hilton in London on Wednesday 19(th) November at
08.40 a.m. UK time (09.40h CET).
The presentation, followed by a Q&A, will be hosted by Dr Edwin Moses, CEO of
Ablynx. The presentation will provide an update on the Company's proprietary key
clinical assets, its partnered programmes and the outlook for the near term
future.
The presentation will be webcast live and can be accessed on the day via this
link or on the homepage of the Ablynx website at www.ablynx.com. A replay of the
webcast will be available for 30 days on the Company's website, under news &
events, past events & presentations. To ensure a timely connection, it is
recommended that users register at least 10 minutes prior to the scheduled
webcast.
About Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies®,
proprietary therapeutic proteins based on single-domain antibody fragments,
which combine the advantages of conventional antibody drugs with some of the
features of small-molecule drugs. Ablynx is dedicated to creating new medicines
which will make a real difference to society. Today, the Company has more than
30 proprietary and partnered programmes in development in therapeutic areas
including inflammation, haematology, oncology and respiratory disease. The
Company has collaborations and significant partnerships with pharmaceutical
companies including AbbVie, Boehringer Ingelheim, Merck & Co, Merck Serono and
Novartis. The Company is headquartered in Ghent, Belgium. More information can
be found on www.ablynx.com.
For more information, please contact
Ablynx:
Dr Edwin Moses
CEO
t: +32 (0)9 262 00 07
m: +44 (0)7771 954 193 /
+32 (0)473 39 50 68
e: edwin.moses(at)ablynx.com
Marieke Vermeersch
Associate Director Investor Relations
t: +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e: marieke.vermeersch(at)ablynx.com
Follow us on Twitter (at)AblynxABLX
Ablynx media relations Consilium Strategic Communications:
Mary-Jane Elliott, Amber Bielecka, Lindsey Neville
t: +44 203 709 5700
e: ablynx(at)consilium-comms.com
pdf format of the press release:
http://hugin.info/137912/R/1871573/658503.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Ablynx via GlobeNewswire
[HUG#1871573]
Unternehmensinformation / Kurzprofil:
Datum: 17.11.2014 - 07:00 Uhr
Sprache: Deutsch
News-ID 352939
Anzahl Zeichen: 3254
contact information:
Town:
Ghent/Zwijnaarde
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 158 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ABLYNX TO PRESENT AT THE JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE IN LONDON"
steht unter der journalistisch-redaktionellen Verantwortung von
Ablynx (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
